Bg pattern

OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet

Ophtesic20 mg/g, ophthalmic gel in single-dose container

Lidocaine hydrochloride

Read this leaflet carefully before starting to use this medicine, as it contains important information for you.

Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor.
  • If you experience side effects, consult your doctor, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What is Ophtesic and what is it used for
  2. What you need to know before using Ophtesic
  3. How to use Ophtesic
  4. Possible side effects
  5. Storage of Ophtesic
  6. Contents of the pack and further information

1. What is Ophtesic and what is it used for

Ophtesic is an ophthalmic anaesthetic gel used during ophthalmic procedures.

This medicine is used to induce a temporary feeling of numbness in the eye before and during certain types of procedures performed by your doctor.

This medicine should start to take effect within 5 minutes of your doctor applying it.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before using Ophtesic

Do not use Ophtesic:

  • If you are allergic to lidocaine, to any other local anaesthetic or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use this medicine.

  • For ophthalmic use only.
  • Prolonged use of this type of ophthalmic anaesthetic may cause corneal opacification.
  • This medicine is for single use and should be discarded immediately after use.

Other medicines and Ophtesic

Tell your doctor if you are taking, have recently taken or might take any other medicines.

Children

If necessary, your doctor may consider using Ophtesic in children.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, consult your doctor before using this medicine.

Driving and using machines

You may have blurred vision for a while after using this medicine. Do not drive or use machines until the effects have worn off.

3. How to use Ophtesic

Before the ophthalmic procedure, your doctor will apply this medicine to your eye(s).

Dosage

Your doctor should cover the surface of your eye(s) and the surrounding area with the gel 5 minutes before the procedure.

The recommended dose is 1 gram spread over the surface of the eye. This dose is usually sufficient to achieve initial anaesthesia. Additional amounts may be used depending on the size of the eye and the duration of the procedure.

1 gram corresponds to approximately one-third of the tube.

Your doctor should not use more than one tube per eye or per procedure.

The gel can be reapplied to maintain the anaesthetic effect.

Method of administration

Your doctor should proceed as follows:

  1. The paper cover of the blister pack should be removed and the tube and nozzle taken out of the sterile blister pack. Their integrity should be checked.

White blister pack with black text indicating “Optiose 20 mg” and black arrows pointing to the ends to open it

  1. The two parts should be assembled by screwing the nozzle onto the thread of the tube and turning it clockwise to pierce the sealed aluminium membrane.

White tube with thread and a separate cylindrical applicator showing a black rotation arrow

  1. The tube should be held upside down and the edge pressed gently to release the gel and cover the surface of the eye and the surrounding area.
  1. The gel should be left in place for 3 to 5 minutes before being rinsed off. The eye or eyelid should not be touched with the tip of the nozzle.
  1. The tube and blister pack should be discarded after use.
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported with an unknown frequency:

  • conjunctival redness
  • changes in the corneal epithelium
  • eye burning sensation
  • punctate corneal inflammation
  • corneal inflammation
  • headache

Reporting of side effects

If you experience any side effects, consult your doctor, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ophtesic

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the tube and carton after EXP. The expiry date is the last day of the month indicated.

Do not store above 25°C.

The product is for single use and should be discarded immediately after use.

Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to a pharmacy for disposal. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and further information

Composition of Ophtesic

  • The active substance is lidocaine: 1 gram of gel contains 20 mg of lidocaine hydrochloride (anhydrous).
  • The other ingredients are: hypromellose (E464), sodium hydroxide (E524) (for pH adjustment), hydrochloric acid (E507) (for pH adjustment), and water for injections.

Appearance and packaging of the product

This medicine is a colourless and transparent gel supplied in a 3.5 gram tube.

Carton of 1, 20 or 100 tubes.

Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

Laboratoires Doliage Development (LDD)

93, rue Jean-Jaurès

92800 Puteaux

France

Local representative

Horus Pharma Ibérica, S.L.U.

Gran Vía Carlos III, 98, 6º

08028 Barcelona – Spain

Manufacturer

RECIPHARM KARLSKOGA AB

Bjökbornsvägen 5- Box 140

691 33 Karlskoga

Sweden

Ar2i S.A. Analyses recherches et innovation instrumentale

Immeuble le carnot

20 avenue edouard herriot

92350 le plessis-robinson

France

This medicine is authorised in the Member States of the European Economic Area under the following names

Germany: Ophtesic 20 mg/g Augengel im Einzeldosisbehältnis

Austria: Ophtesic 20 mg/g Augengel im Einzeldosisbehältnis

Belgium: Ophtesic 20 mg/g, ooggel in verpakking voor éénmalig gebruik/ Ophtesic 20 mg/g Augengel im Einzeldosisbehältnis/ Ophtesic 20 mg/g gel ophtalmique en récipient unidose

Denmark: Ophtesic, øjengel i enkeltdosisbeholder

Spain: Ophtesic 20 mg/g, gel oftálmico en envase unidosis

Finland: Ophtesic 20 mg/g, silmägeeli, kerta-annospakkaus/ Ophtesic 20 mg/g ögongel i endosbehållare.

France: OPHTESIC 20 mg/g, gel ophtalmique en récipient unidose

Italy: Ophtesic 20 mg/g, gel oftalmico in contenitore monodose.

Luxembourg: Ophtesic 20 mg/g gel ophtalmique en récipient unidose

Norway: Ophtesic 20 mg/g øyegel i endosebeholder

Netherlands: OPHTESIC 20 mg/g ooggel in verpakking voor éénmalig gebruik

Poland: OPHTESIC 20mg/g zel do oczu w pojemniku jednodawkowym

Sweden: Ophtesic 20 mg/g ögongel i endosbehållare

Date of last revision of this leaflet: June/2023

Other sources of information

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER

Discuss questions about OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER?
OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER?
The active ingredient in OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER is lidocaine. This information helps identify medicines with the same composition but different brand names.
Who manufactures OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER?
OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER is manufactured by Laboratoires Doliage Developpement. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER?
Other medicines with the same active substance (lidocaine) include COLIROFTA ANESTHETIC 5 mg/ml + 0.5 mg/ml EYE DROPS SOLUTION, COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION, OXIBUPROCAINE HYDROCHLORIDE AGEPHA 4 MG/ML EYE DROPS IN SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media